MASS SPECTROMETRY AND SYSTEMS FOR DRUG DELIVERY

质谱和药物输送系统

• 批准号: 8168770
• 负责人: Patrick J. Sinko
• 金额: $ 0.01万
• 依托单位: WASHINGTON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-03-10 至 2010-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8168770
• 关键词: Acquired Immunodeficiency Syndrome; Asthma; Biological; Chemicals; Computer Retrieval of Information on Scientific Projects Database; Diagnostic; Drug Delivery Systems; Evaluation; Funding; Grant; Institution; Malignant Neoplasms; Mass Spectrum Analysis; Pharmaceutical Preparations; Polymers; Research; Research Personnel; Resources; Source; System; Technology; Therapeutic; United States National Institutes of Health; design; molecular scale

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The Sinko group is focused on investigating the mechanisms and developing systems for enhancing the delivery of therapeutic and diagnostic agents using polymers in a variety of physical forms in order to specifically target specific biological situations. The Sinko group's research efforts focus on the design, fabrication and evaluation of molecular-scale drug and diagnostic delivery technologies applied broadly to asthma, AIDS, chemical counterterrorism, and cancer.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 Sinko集团专注于研究机制和开发系统，用于使用各种物理形式的聚合物来增强治疗和诊断剂的递送，以便专门针对特定的生物情况。 Sinko集团的研究重点是设计、制造和评估广泛应用于哮喘、艾滋病、化学反恐和癌症的分子级药物和诊断输送技术。